Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.
20
The right combination of estrogen and a selective estrogen receptor modulator (SERM), which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk, Yale researchers report in an abstract presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia, October 17-21.
U.S. scientists say drugs being tested for treatment of a variety of allergies, asthma and autoimmune diseases might lead to the development of breast cancer.
Bionovo Inc. announced today the publication of results from its study on the inhibitory effect of tamoxifen on estrogen receptor beta (ERb) gene regulation. The results of the study, which will be published in Molecular and Cellular Endocrinology, demonstrate that tamoxifen inhibits the beneficial effects of ERb in the prevention of breast cancer cell proliferation.
19
Nanosphere, Inc., a leader in the development and commercialization of advanced molecular diagnostics systems, today announced that a research team at Northwestern University's International Institute for Nanotechnology found that an ultrasensitive nanoparticle-based assay, 300 times more sensitive than commercial immunoassays, is capable of detecting previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy.
The U.S. Food and Drug Administration (FDA) on Monday approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women age 10 to 25.
The U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be approved for kidney cancer since 2005. Votrient is an oral medication that interferes with angiogenesis, the growth of new blood vessels needed for solid tumors to grow and survive.
Today, Lung Cancer Alliance (LCA) announced the launch of the Shine a Light National Lung Cancer Vigil, a campaign designed to raise awareness of lung cancer during November, Lung Cancer Awareness Month. Building on the success of vigils held across the country over the past three years, LCA is encouraging an even greater number of volunteers to host a vigil in their community.
17
When Geri Bell lost her breasts to cancer, she joked that at least she wouldn't need a bra. When she lost her hair to chemotherapy, she'd say how her wig made it so easy to get ready in the morning.
At 15, she watched an aunt struggle with breast cancer. Then a cousin. Soon after, Mattie McCalister was stricken with the same disease that would afflict so many of the women in her family.
Though breast cancer is still deadly, it's not as fearsome a diagnosis as it may have been a few decades ago. In 1975, the five-year survival rate was 75 percent. Today, it's 89 percent.
We care about your feedback. Let us know how we can improve your CancerCompass experience.